964 related articles for article (PubMed ID: 15451153)
1. A randomized, double-blind, placebo-controlled study of permanent cardiac pacing for the treatment of recurrent tilt-induced vasovagal syncope. The vasovagal syncope and pacing trial (SYNPACE).
Raviele A; Giada F; Menozzi C; Speca G; Orazi S; Gasparini G; Sutton R; Brignole M;
Eur Heart J; 2004 Oct; 25(19):1741-8. PubMed ID: 15451153
[TBL] [Abstract][Full Text] [Related]
2. The vasovagal Syncope and pacing (Synpace) trial: rationale and study design.
Raviele A; Giada F; Sutton R; Alboni P; Brignole M; Del Rosso A; Di Girolamo E; Luise R; Menozzi C
Europace; 2001 Oct; 3(4):336-41. PubMed ID: 11678394
[TBL] [Abstract][Full Text] [Related]
3. The expectation effect and cardiac pacing for refractory vasovagal syncope.
Sud S; Massel D; Klein GJ; Leong-Sit P; Yee R; Skanes AC; Gula LJ; Krahn AD
Am J Med; 2007 Jan; 120(1):54-62. PubMed ID: 17208080
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of tilt training in patients with vasovagal syncope.
Gajek J; Zyśko D; Mazurek W
Kardiol Pol; 2006 Jun; 64(6):602-8; discussion 609-10. PubMed ID: 16810579
[TBL] [Abstract][Full Text] [Related]
5. Closed loop stimulation in prevention of vasovagal syncope. Inotropy Controlled Pacing in Vasovagal Syncope (INVASY): a multicentre randomized, single blind, controlled study.
Occhetta E; Bortnik M; Audoglio R; Vassanelli C;
Europace; 2004 Nov; 6(6):538-47. PubMed ID: 15519257
[TBL] [Abstract][Full Text] [Related]
6. Second Vasovagal Pacemaker Study (VPS II): rationale, design, results, and implications for practice and future clinical trials.
Sheldon R; Connolly S;
Card Electrophysiol Rev; 2003 Dec; 7(4):411-5. PubMed ID: 15071266
[TBL] [Abstract][Full Text] [Related]
7. The role of tilt training in preventing recurrent syncope in patients with vasovagal syncope: a prospective and randomized study.
Duygu H; Zoghi M; Turk U; Akyuz S; Ozerkan F; Akilli A; Erturk U; Onder R; Akin M
Pacing Clin Electrophysiol; 2008 May; 31(5):592-6. PubMed ID: 18439174
[TBL] [Abstract][Full Text] [Related]
8. The effect of atropine in vasovagal syncope induced by head-up tilt testing.
Santini M; Ammirati F; Colivicchi F; Gentilucci G; Guido V
Eur Heart J; 1999 Dec; 20(23):1745-51. PubMed ID: 10562483
[TBL] [Abstract][Full Text] [Related]
9. Prevention of Syncope Trial (POST): a randomized, placebo-controlled study of metoprolol in the prevention of vasovagal syncope.
Sheldon R; Connolly S; Rose S; Klingenheben T; Krahn A; Morillo C; Talajic M; Ku T; Fouad-Tarazi F; Ritchie D; Koshman ML;
Circulation; 2006 Mar; 113(9):1164-70. PubMed ID: 16505178
[TBL] [Abstract][Full Text] [Related]
10. Comparison of cardiac pacing with drug therapy in the treatment of neurocardiogenic (vasovagal) syncope with bradycardia or asystole.
Sra JS; Jazayeri MR; Avitall B; Dhala A; Deshpande S; Blanck Z; Akhtar M
N Engl J Med; 1993 Apr; 328(15):1085-90. PubMed ID: 8455666
[TBL] [Abstract][Full Text] [Related]
11. The effect of dual-chamber closed-loop stimulation on syncope recurrence in healthy patients with tilt-induced vasovagal cardioinhibitory syncope: a prospective, randomised, single-blind, crossover study.
Russo V; Rago A; Papa AA; Golino P; Calabrò R; Russo MG; Nigro G
Heart; 2013 Nov; 99(21):1609-13. PubMed ID: 23723446
[TBL] [Abstract][Full Text] [Related]
12. Dual-chamber pacing in the treatment of neurally mediated tilt-positive cardioinhibitory syncope : pacemaker versus no therapy: a multicenter randomized study. The Vasovagal Syncope International Study (VASIS) Investigators.
Sutton R; Brignole M; Menozzi C; Raviele A; Alboni P; Giani P; Moya A
Circulation; 2000 Jul; 102(3):294-9. PubMed ID: 10899092
[TBL] [Abstract][Full Text] [Related]
13. Closed-loop cardiac pacing vs. conventional dual-chamber pacing with specialized sensing and pacing algorithms for syncope prevention in patients with refractory vasovagal syncope: results of a long-term follow-up.
Palmisano P; Zaccaria M; Luzzi G; Nacci F; Anaclerio M; Favale S
Europace; 2012 Jul; 14(7):1038-43. PubMed ID: 22247273
[TBL] [Abstract][Full Text] [Related]
14. Benefit of dual-chamber pacing with Closed Loop Stimulation in tilt-induced cardio-inhibitory reflex syncope (BIOSync trial): study protocol for a randomized controlled trial.
Brignole M; Tomaino M; Aerts A; Ammirati F; Ayala-Paredes FA; Deharo JC; Del Rosso A; Hamdan MH; Lunati M; Moya A; Gargaro A;
Trials; 2017 May; 18(1):208. PubMed ID: 28472974
[TBL] [Abstract][Full Text] [Related]
15. Pacemaker therapy in patients with neurally mediated syncope and documented asystole: Third International Study on Syncope of Uncertain Etiology (ISSUE-3): a randomized trial.
Brignole M; Menozzi C; Moya A; Andresen D; Blanc JJ; Krahn AD; Wieling W; Beiras X; Deharo JC; Russo V; Tomaino M; Sutton R;
Circulation; 2012 May; 125(21):2566-71. PubMed ID: 22565936
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcome of patients with asystole induced by head-up tilt test.
Barón-Esquivias G; Pedrote A; Cayuela A; Valle JI; Fernández JM; Arana E; Fernández M; Morales F; Burgos J; Martínez-Rubio A
Eur Heart J; 2002 Mar; 23(6):483-9. PubMed ID: 11863351
[TBL] [Abstract][Full Text] [Related]
17. Pacemaker therapy for prevention of syncope in patients with recurrent severe vasovagal syncope: Second Vasovagal Pacemaker Study (VPS II): a randomized trial.
Connolly SJ; Sheldon R; Thorpe KE; Roberts RS; Ellenbogen KA; Wilkoff BL; Morillo C; Gent M;
JAMA; 2003 May; 289(17):2224-9. PubMed ID: 12734133
[TBL] [Abstract][Full Text] [Related]
18. Implications of mechanism of bradycardia on response to pacing in patients with unexplained syncope.
Sud S; Klein GJ; Skanes AC; Gula LJ; Yee R; Krahn AD
Europace; 2007 May; 9(5):312-8. PubMed ID: 17376795
[TBL] [Abstract][Full Text] [Related]
19. Does cardiac pacing reduce syncopal recurrences in cardioinhibitory vasovagal syncope patients selected with head-up tilt test? Analysis of a 5-year follow-up database.
Russo V; Rago A; De Rosa M; Papa AA; Simova I; Petrov I; Bonev N; Gargaro A; Golino P; Nigro G
Int J Cardiol; 2018 Nov; 270():149-153. PubMed ID: 29980368
[TBL] [Abstract][Full Text] [Related]
20. Benefit of pacemaker therapy in patients with presumed neurally mediated syncope and documented asystole is greater when tilt test is negative: an analysis from the third International Study on Syncope of Uncertain Etiology (ISSUE-3).
Brignole M; Donateo P; Tomaino M; Massa R; Iori M; Beiras X; Moya A; Kus T; Deharo JC; Giuli S; Gentili A; Sutton R;
Circ Arrhythm Electrophysiol; 2014 Feb; 7(1):10-6. PubMed ID: 24336948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
